These data suggest that decreasing Akt2 in the RPE inhibits diabetes-induced retinal abnormalities in mice, through the upregulation of Akt1, and, in turn inhibition of the GSK3β/NF-κB-regulated inflammatory response. This evidence concerns the gene AKT2 and diabetes mellitus.